Small Cell Lung Cancer: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 57 year old male presented to his physicians office with complaints of cough and back pain.  His cough is non-productive and has been present for approximately one month.  The back pain is exacerbated by cough and has no radicular aspects. The patient also notes a 12 pound weight loss over the preceding six months.  His past history includes moderately well controlled hypertension and glucose intolerance.  He has a social history that includes a 37 pack-year smoking history. No known exposures to asbestos and he did not serve in the military. A chest x-ray reveals a 3.5 cm mid-right lung central mass. A CT of the chest abdomen and pelvis confirms the mass along with subcarinal adenopathy measuring 2.5 cm in greatest dimension and three low attenuation lesions involving both lobes of the liver.

Learning Objectives

  • Examine what chemotherapy to use as initial therapy as well as subsequent therapy in extensive disease (ED) small cell lung cancer (SCLC)
  • Explain the effectiveness of chemotherapy in both sensitive and refractory relapse disease in patients with SCLC
  • Identify the role of radiotherapy, i.e. prophylactic cranial irradiation and thoracic radiotherapy, in the treatment of ED-SCLC

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on April 22, 2018. Participants must complete all necessary course components by this date to receive credit.